All In MedTech

Device Trial Radar · NCT03920358

FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study

Last checked: Nov 20, 2026Latest source record: Jan 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

156

Actual

Start

Apr 10, 2019

Primary completion

Jun 9, 2023

Study completion Dec 30, 2027

Sponsor

Lead sponsor
Microvention-Terumo, Inc.Public (4543.T)
Sponsor type
Industry
First posted
Apr 18, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms

Conditions

  • Intracranial Aneurysm

Interventions

  • FRED, FRED Jr and FRED XDevice

    Subjects aged ≥ 18 requiring treatment for an unruptured or recanalized intracranial aneurysm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of complete aneurysm occlusion without associated stenosis of the parent artery (> 50%)Time frame: 12 months
  2. Morbidity RateTime frame: 6 months
  3. Mortality RateTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Universitätsklinikum Erlangen

    Erlangen, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.